Stocks and Investing Stocks and Investing
Mon, October 15, 2018
Fri, October 12, 2018

Reni Benjamin Maintained (ADMA) at Buy with Decreased Target to $10 on, Oct 12th, 2018


Published on 2024-10-26 09:29:28 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of Raymond James, Maintained "ADMA Biologics, Inc." (ADMA) at Buy with Decreased Target from $11 to $10 on, Oct 12th, 2018.

Reni has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Reni's Rating of Hold.



This is the rating of the analyst that currently disagrees with Reni


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $12 on, Friday, July 27th, 2018
Contributing Sources